EMA Authorised: Duloxetine Lilly (duloxetine) — Eli Lilly Nederland B.V.

View source ↗

Summary

The European Medicines Agency authorised duloxetine (Lilly) by Eli Lilly Nederland B.V. for neuralgia, diabetic neuropathies, and major depressive disorder, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Major Depressive Disorder
• Neuralgia

Drugs mentioned

• Duloxetine Lilly (duloxetine)

Snippet

Status: Authorised. Therapeutic area: Neuralgia;Diabetic Neuropathies;Depressive Disorder, Major. MAH: Eli Lilly Nederland B.V.. Decision date: 20/06/2024